biotech · Relapsed or Refractory B-cell Malignancies · Solid Tumor · RXRX
RECURSION PHARMACEUTICALS
RECURSION PHARMACEUTICALS, INC.
RECURSION PHARMACEUTICALS clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Staten Island, USA HQ
11 Employees
Public company Type
RXRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Staten Island, USA
- Employees
- 11
- Programs
- 9
- Drugs
- 2
- Patents
- 4
RECURSION PHARMACEUTICALS projects
0 ClinicalTrials.gov programs sponsored by RECURSION PHARMACEUTICALS.
RECURSION PHARMACEUTICALS has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does RECURSION PHARMACEUTICALS have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.